Precision Biosciences DTIL Insider Ownership

NASDAQ DTIL
$6.78 +0.07 (+1.04%)
At close: Oct 22, 2026 · 4:00 PM EDT

Insider Holdings by Owner

911.04K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
2.90%
▲+0.018% pp QoQ
Shares Held by Insiders
766.27K
filed for Sep 2026
▲+0.62% QoQ
Shares Outstanding
26.43Mn
26,433,558 shares
Direct Holdings
766.27K
Indirect: 0
Net Shares Traded (QoQ)
+4.74K
net buying in Sep 2026
Insiders Holding Shares
13
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Over the trailing 12 months, DTIL insiders bought $63,215 worth of shares (11.82K shares) and sold $447,255 worth (108.08K shares) in open-market trades.

Form 4 Holdings

Insiders Holding DTIL

Insiders 13
Shares held 911.04K
Of outstanding 3.45%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Michael Amoroso President And Ceo 243,392 0 243,392 26.7% 19 Feb, 2026
2 Derek Jantz Chief Scientific Officer 135,159 0 135,159 14.8% 09 Jun, 2022
3 John Alexander Kelly Chief Financial Officer 125,883 0 125,883 13.8% 19 Feb, 2026
4 J. Jefferson Smith Chief Research Officer 121,926 0 121,926 13.4% 19 Feb, 2026
5 Dario Scimeca General Counsel And Secretary 56,457 0 56,457 6.2% 19 Feb, 2026
6 Kevin Buehler Director 49,137 0 49,137 5.4% 22 May, 2026
7 Geno J Germano Director 47,492 0 47,492 5.2% 29 Sep, 2026
8 Melinda Brown Director 45,481 0 45,481 5.0% 29 Sep, 2026
9 Stanley Frankel Director 41,478 0 41,478 4.6% 29 Sep, 2026
10 Shari Lisa Pire Director 35,028 0 35,028 3.8% 22 May, 2026
11 Alan List Chief Medical Officer 4,488 0 4,488 0.5% 03 May, 2024
12 Samuel C. Wadsworth Director 4,202 0 4,202 0.5% 07 May, 2024
13 Shane Barton Vp Corporate Controller 917 0 917 0.1% 09 Jun, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

527 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
25 Sep, 2026 Melinda Brown Director Acquired P 1,135 $6.27 $7.12K 45,481 Direct
25 Sep, 2026 Geno J Germano Director Acquired P 2,609 $6.28 $16.38K 47,492 Direct
28 Sep, 2026 Stanley Frankel Director Acquired P 1,000 $6.00 $6.00K 41,478 Direct
03 Jun, 2026 Stanley Frankel Director Acquired A 20,979 $0.00 $0 20,979 Direct
03 Jun, 2026 Geno J Germano Director Acquired A 20,979 $0.00 $0 20,979 Direct
03 Jun, 2026 Melinda Brown Director Acquired A 20,979 $0.00 $0 20,979 Direct
03 Jun, 2026 Shari Lisa Pire Director Acquired A 20,979 $0.00 $0 20,979 Direct
03 Jun, 2026 Kevin Buehler Director Acquired A 20,979 $0.00 $0 20,979 Direct
01 Jun, 2026 Dario Scimeca General Counsel And Secretary Acquired A 107,604 $0.00 $0 107,604 Direct
01 Jun, 2026 Michael Amoroso President And Ceo Acquired A 573,888 $0.00 $0 573,888 Direct
01 Jun, 2026 J. Jefferson Smith Chief Research Officer Acquired A 57,389 $0.00 $0 57,389 Direct
01 Jun, 2026 John Alexander Kelly Chief Financial Officer Acquired A 193,688 $0.00 $0 193,688 Direct
20 May, 2026 Shari Lisa Pire Director Acquired M 21,000 — — 35,028 Direct
20 May, 2026 Kevin Buehler Director Acquired M 21,000 — — 49,137 Direct
20 May, 2026 Melinda Brown Director Acquired M 21,000 — — 44,346 Direct
20 May, 2026 Geno J Germano Director Acquired M 21,000 — — 44,883 Direct
20 May, 2026 Stanley Frankel Director Acquired M 21,000 — — 40,478 Direct
20 May, 2026 Geno J Germano Director Disposed M 21,000 $0.00 $0 0 Direct
20 May, 2026 Kevin Buehler Director Disposed M 21,000 $0.00 $0 0 Direct
20 May, 2026 Melinda Brown Director Disposed M 21,000 $0.00 $0 0 Direct